Trustmark National Bank Trust Department’s Celgene Corp CELG Stock Holding History

Trustmark National Bank Trust Department’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-17	Closed	-$2K	–	600
2019 Q2	$2K	Hold	17	–	–	﹤0.01%	514
2019 Q1	$2K	Hold	17	–	–	﹤0.01%	522
2018 Q4	$1K	Hold	17	–	–	﹤0.01%	578
2018 Q3	$2K	Buy	+17	New	+$1.5K	﹤0.01%	529
2016 Q2	–	Sell	-8,560	Closed	-$857K	–	347
2016 Q1	$857K	Sell	8,560 -3,804	-31%	-$392K	0.12%	142
2015 Q4	$1.48M	Sell	12,364 -4,260	-26%	-$493K	0.2%	104
2015 Q3	$1.8M	Buy	16,624 +12,880	+344%	+$1.6M	0.25%	89
2015 Q2	$434K	Hold	3,744	–	–	0.06%	220
2015 Q1	$432K	Sell	3,744 -50	-1%	-$5.97K	0.06%	236
2014 Q4	$424K	Buy	3,794 +50	+1%	+$5.27K	0.06%	216
2014 Q3	$354K	Hold	3,744	–	–	0.05%	265
2014 Q2	$321K	Hold	3,744	–	–	0.04%	285
2014 Q1	$262K	Sell	3,744 -650	-15%	-$51.5K	0.03%	306
2013 Q4	$371K	Buy	4,394 +130	+3%	+$10.3K	0.04%	257
2013 Q3	$329K	Hold	4,264	–	–	0.04%	261
2013 Q2	$249K	Buy	+4,264	New	+$257K	0.03%	277

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Trustmark National Bank Trust Department's CELG Position: Q3 2019 in Review

Trustmark National Bank Trust Department sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 17 shares — an estimated $2K sold.

Trustmark National Bank Trust Department first reported a position in CELG in Q2 2013 and held it in 16 quarters. The position peaked at $1.8M in Q3 2015. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

Trustmark National Bank Trust Department reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
Trustmark National Bank Trust Department sold 17 Celgene Corp shares in Q3 2019, an estimated $2K.
Trustmark National Bank Trust Department first reported a position in Celgene Corp in Q2 2013 and held it in 16 quarters.
Trustmark National Bank Trust Department's Celgene Corp position peaked at $1.8M in Q3 2015.
1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Trustmark National Bank Trust Department's 13F filing for Q3 2019, filed 14 Nov 2019.